Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
暂无分享,去创建一个
R. Giugliano | M. Sabatine | E. Braunwald | D. Morrow | S. Murphy | C. McCabe | C. Gibson | P. Burton | David A. Morrow | C. Mccabe | C. Gibson | Marc S. Sabatine | Paul Burton | M. Sabatine
[1] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes , 2004 .
[2] Sunil V. Rao,et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.
[3] J. J. Griffin,et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. , 2004, Journal of the American College of Cardiology.
[4] Samin K. Sharma,et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. , 2004, Journal of the American College of Cardiology.
[5] A. Defranco,et al. Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention , 2004, Circulation.
[6] S. Reis,et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. , 2004, Journal of the American College of Cardiology.
[7] D. Sane,et al. The cardiovascular effects of erythropoietin. , 2003, Cardiovascular research.
[8] R. Califf,et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. , 2003, Journal of the American College of Cardiology.
[9] Paul W Armstrong,et al. Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.
[10] Alan C. Wilson,et al. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. , 2002, American heart journal.
[11] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[12] J. Griffith,et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.
[13] H. Heidbuchel,et al. Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial , 2002, Circulation.
[14] H. Krumholz,et al. Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.
[15] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[16] W. Rand,et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.
[17] J. Marshall,et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.
[18] InTIME-II Investigators,et al. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. , 2000, European heart journal.
[19] A. Skene,et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. , 2000, Circulation.
[20] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[21] J S Alpert,et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.
[22] S. Kleinman,et al. A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care , 1999 .
[23] E. Antman,et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.
[24] R. Giugliano,et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. , 1998, Circulation.
[25] E. Braunwald,et al. Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction. , 1998, Circulation.
[26] E. Braunwald,et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. , 1997, Circulation.
[27] P. Levy,et al. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. , 1996, The Journal of trauma.
[28] E. Antman. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. , 1996, Circulation.
[29] C. Cannon,et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. , 1994, Journal of the American College of Cardiology.
[30] E. Antman. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. , 1994, Circulation.
[31] J. Mcmanus. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .
[32] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[33] W. Kannel,et al. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. , 1994, American heart journal.
[34] G. J. Crystal,et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. , 1993, The American journal of physiology.
[35] G. Ewy,et al. Markedly decreased coronary blood flow in secondary polycythemia. , 1992, American heart journal.
[36] K. Mann,et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. , 1991, Annals of internal medicine.
[37] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[38] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[39] H. Gewirtz,et al. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. , 1986, Circulation.
[40] Lowe Gd,et al. Blood rheology and thrombosis. , 1981 .
[41] C. Forbes,et al. Blood rheology and thrombosis. , 1981, Clinics in haematology.
[42] J. Dormandy,et al. Clinical, Haemodynamic, Rheological, and Biochemical Findings in 126 Patients with Intermittent Claudication , 1973, British medical journal.
[43] W. J. Powell,et al. Effect of acute anemia on experimental myocardial ischemia. , 1973, The American journal of cardiology.